OR WAIT null SECS
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
An observational cohort study found that the risk of major congenital malformations for infants who were exposed to angiotensin-converting enzyme (ACE) inhibitors during their first trimester increased by a factor of more than 2, while exposure to other antihypertensive medications did not demonstrate an increased risk.